Expects to end the year with approximately $13.4M in cash and cash equivalents, representing net cash used in the fourth quarter of approximately $7.8M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AXDX:
- Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
- Accelerate Diagnostics files to sell units, no amount given
- Accelerate Diagnostics announces collaboration with Bruker
- Accelerate Diagnostics Reports Third Quarter 2023 Results
Questions or Comments about the article? Write to editor@tipranks.com